SCHEMBL7572389

SCHEMBL7572389

NC(=O)c1cccnc1-c1ccc2[nH]ncc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 3/20 0.50
RIPK2 O43353 1/20 0.50
GSK3B P49841 4/20 0.48
CDK5 Q00535 4/20 0.48
CLK4 Q9HAZ1 4/20 0.48
DYRK3 O43781 3/20 0.48
CLK2 P49760 3/20 0.48
DYRK1A Q13627 3/20 0.48
CLK1 P49759 2/20 0.48
DYRK1B Q9Y463 2/20 0.48
CLK3 P49761 1/20 0.48
CDK5R1 Q15078 1/20 0.48
DYRK2 Q92630 1/20 0.48
ROCK2 O75116 3/20 0.47
PIM1 P11309 3/20 0.47
AR P10275 1/20 0.47
DAPK3 O43293 3/20 0.47
ROCK1 Q13464 3/20 0.47
CDC7 O00311 2/20 0.47
PRKD3 O94806 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30627398 1.00 TGFBR1 (0.50) TGFBR1RIPK2GSK3BCDK5CLK4
SCHEMBL15637538 0.83 TGFBR1 (0.60) TGFBR1RIPK2ROCK2ARROCK1
SCHEMBL17909871 0.82 RIPK2 (0.51) TGFBR1RIPK2GSK3BCDK5CLK4
SCHEMBL30759594 0.81 BTK (0.52) CDK5CLK4DYRK1BPIM1DAPK3
SCHEMBL8523957 0.81 PI4K2A (0.51) PIM1ARHIPK2STK17AMAP4K4
SCHEMBL3380293 0.80 TRPA1 (0.59) TGFBR1GSK3BCDK5CLK4DYRK3
SCHEMBL15640023 0.78 TGFBR1 (0.70) TGFBR1GSK3BCDK5CLK4DYRK3
SCHEMBL31032063 0.78 PARP1 (0.51) RIPK2PIM1CDC7HIPK2STK17A
SCHEMBL5014101 0.77 CLK1 (0.64) TGFBR1GSK3BCDK5CLK4DYRK3
SCHEMBL31032103 0.77 NPC1 (0.57) TGFBR1GSK3BDYRK1APIM1AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1259487-A1 2-AMINO-NICOTINAMIDE DERIVATIVES AND THEIR USE AS VEGF-RECEPTOR TYROSINE KINASE INHIBITORS Novartis AG (CH) 2002-11-27 EP disclosed
WO-2001055114-A1 2-AMINO-NICOTINAMIDE DERIVATIVES AND THEIR USE AS VEGF-RECEPTOR TYROSINE KINASE INHIBITORS NOVARTIS AG (CH) 2001-08-02 WO disclosed